{"nct_id":"NCT00441701","title":"Study to Evaluate the Safety and Dose-Range of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (MK-7123-012)","status":"TERMINATED","status_verified_date":"2018-12","start_date":"2006-12-01","start_date_type":"ACTUAL","primary_completion_date":"2008-10-01","primary_completion_date_type":"ACTUAL","completion_date":"2008-10-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}